About MET Biotechnology
MET Biotechnology is a private company based in Culver City, California, incorporated in 2021 in Delaware. It has reported $2,000,000 raised in one offering on Form D since February 2024. Its chief executive is Ting-Hsiang Wu.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 25, 2024 | Feb 9, 2024 | $2,000,000fully sold | 4 | $500K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MET Biotechnology's Form D filed Feb 9, 2024.
TW
Ting-Hsiang Wu
Chief Executive Officer and director
TW
Tung-Yu Wu
Chief Executive Officer and director
PC
Pei-Yu Chiou
Director
MT
Michael Teitell
Director